怀孕记录在24年内发生的变化 - 产性和发作控制
Frank Vajda1, Terence O'Brien2, Janet Graham3
1Departments of Medicine and Neurosciences, The Royal Melbourne Hospital, The University of Melbourne, Parkville, VIC 3050, Australia; Department of Neuroscience, Monash University, Melbourne, VIC 3004, Australia.
Epilepsy & behavior : E&B
|October 15, 2023
概括
新的抗发作药物 (ASM) 治疗孕妇,减少胎儿形,改善了发作控制. 这项研究追踪了24年来ASM使用的变化,显示了显著的益处.
科学领域:
- 神经学 神经学
- 甲状腺学 甲状腺学
- 药物监督 药物监督 药物监督
背景情况:
- 会影响生育年龄的女性.
- 抗发作药物 (ASM) 在怀孕期间存在风险.
- 监测ASM趋势和结果至关重要.
研究的目的:
- 分析24年来针对女性 (WWE) 处方的ASM的趋势.
- 为了将ASM变化与胎儿形率,类型和发作自由度相关联.
主要方法:
- 澳大利亚怀孕登记 (APR) 数据的回顾性分析.
- 追踪特定ASM的处方模式 (瓦尔酸盐,卡巴马西平,拉莫特里金, levetiracetam,托皮拉玛酸).
- 与报告的胎儿形和母亲控制的相关性.
主要成果:
- 瓦尔酸盐和卡巴马西平的使用量下降; levetiracetam的使用量增加.
- 托皮拉马特的使用显示了与恶化形相关的暂时上升.
- 严重的形减少,轻微的形增加;发作自由度有所改善.
结论:
- 在孕妇中增加使用较新的ASM与减少胎儿形频率和严重程度有关.
- 新的ASM也与患者女性的控制改善相关.
- 这些发现支持转向更新的ASM来治疗怀孕期间的.
相关概念视频
Teratogenicity
2.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K
Seizures: Classification
378
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
378
Arteries of the Lower Limbs
194
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
194
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
318
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
318
Antiepileptic Drugs: GABAergic Pathway Potentiators
426
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
426


